2026 Q2 Portfolio Activity
In 2026 Q2, Blue Owl Capital Holdings LP maintained a portfolio of 96 distinct positions. The most significant new addition was SPACE EXPLORATION TECHN CORP, now representing 35.97% of the total fund value. They heavily accumulated shares in DELL TECHNOLOGIES INC, increasing the position by 137.1%. Conversely, Blue Owl Capital Holdings LP completely exited their position in ENGENE HOLDINGS INC.
Position History
hover any row below to update
Loading…
Total Positions
96
Quarter
2026 Q2
Top Holding
SPCX (36.0%)
Top 10 Concentration
78.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 96
Blue Owl Capital Holdings LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPCX
SPACE EXPLORATI...
|
ETF | 35.97% | — |
#1
Prev: #—
|
9.5 |
—
|
1,398,815 | — |
NEW
|
1,398,815 | $239,001,531 |
$170.86
-1.4%
|
2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
AKTS
AKTIS ONCOLOGY ...
|
Healthcare | 14.89% | 15.20% |
#2
1
Prev: #1
|
6.0 |
—
|
-91,129 | -2.9% |
P
S
|
3,070,219 | $98,953,158 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 4.22% | 7.29% |
#3
2
Prev: #5
|
3.2 |
—
|
-370,000 | -19.4% |
P
S
|
1,539,764 | $28,039,102 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 4.21% | 8.61% |
#4
2
Prev: #2
|
4.7 |
—
|
2,043,150 | 28.7% |
P
S
|
9,163,157 | $27,947,629 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
NCDL
NUVEEN CHURCHIL...
|
Financial Services | 4.01% | 7.33% |
#5
1
Prev: #4
|
3.1 |
—
|
no change | no change |
P
S
|
2,143,626 | $26,623,835 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 3.94% | 5.49% |
#6
1
Prev: #7
|
1.6 |
—
|
-276,000 | -27.4% |
P
S
|
729,929 | $26,160,655 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
COF
CAPITAL ONE FIN...
|
Financial Services | 3.62% | — |
#7
Prev: #—
|
4.9 |
—
|
119,757 | — |
NEW
|
119,757 | $24,025,649 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
OBDC
BLUE OWL CAPITA...
|
Financial Services | 3.35% | 6.08% |
#8
2
Prev: #6
|
2.3 |
—
|
no change | no change |
P
S
|
2,045,070 | $22,229,911 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
FISN
DEEP FISSION IN...
|
Industrials | 2.22% | — |
#9
Prev: #—
|
4.4 |
—
|
1,333,333 | — |
NEW
|
1,333,333 | $14,719,996 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
DELL
DELL TECHNOLOGI...
|
Technology | 2.14% | 0.61% |
#10
20
Prev: #30
|
3.9 |
—
|
19,062 | 137.1% |
P
S
|
32,961 | $14,221,353 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
HLLY
HOLLEY INC
|
Consumer Cyclical | 1.68% | 3.49% |
#11
1
Prev: #10
|
1.2 |
—
|
140,000 | 3.3% |
P
S
|
4,376,888 | $11,161,064 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.64% | 3.16% |
#12
1
Prev: #11
|
1.2 |
—
|
-150,000 | -16.4% |
P
S
|
762,594 | $10,905,094 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 1.47% | 0.47% |
#13
20
Prev: #33
|
3.6 |
—
|
926,667 | 277.5% |
P
S
|
1,260,544 | $9,744,005 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 1.37% | 2.14% |
#14
2
Prev: #12
|
2.5 |
—
|
63,600 | 11.7% |
P
S
|
608,600 | $9,092,484 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 1.28% | — |
#15
Prev: #—
|
4.0 |
—
|
874,542 | — |
NEW
|
874,542 | $8,483,057 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.19% | 4.18% |
#16
8
Prev: #8
|
3.0 |
—
|
682,551 | 23.2% |
P
S
|
3,624,076 | $7,936,726 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CNDT
CONDUENT INC
|
Technology | 1.11% | 1.73% |
#17
4
Prev: #13
|
1.4 |
—
|
no change | no change |
P
S
|
5,036,595 | $7,353,429 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.03% | 1.44% |
#18
2
Prev: #16
|
1.4 |
—
|
no change | no change |
P
S
|
61,455 | $6,823,349 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.96% | — |
#19
Prev: #—
|
3.9 |
—
|
450,000 | — |
NEW
|
450,000 | $6,367,500 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.92% | 1.70% |
#20
6
Prev: #14
|
0.4 |
—
|
-120,000 | -39.7% |
P
S
|
182,638 | $6,098,283 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.83% | 1.05% |
#21
4
Prev: #25
|
2.3 |
—
|
5,000 | 16.0% |
P
S
|
36,259 | $5,541,100 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
IMA
IMAGENEBIO INC
|
Healthcare | 0.81% | 1.29% |
#22
3
Prev: #19
|
0.8 |
—
|
-41,645 | -4.3% |
P
S
|
917,692 | $5,414,383 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
COMPASS PATHWAY...
|
|
CALL Option | 0.78% | — |
#23
Prev: #—
|
3.8 |
—
|
1,670,500 | — |
NEW
|
1,670,500 | $5,180,485 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.72% | — |
#24
Prev: #—
|
3.8 |
—
|
260,000 | — |
NEW
|
260,000 | $4,776,200 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 0.68% | 1.34% |
#25
7
Prev: #18
|
0.3 |
—
|
-110,000 | -20.1% |
P
S
|
437,552 | $4,511,161 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.65% | 0.51% |
#26
6
Prev: #32
|
3.3 |
—
|
250,000 | 166.7% |
P
S
|
400,000 | $4,332,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
LENZ
LENZ THERAPEUTI...
|
Healthcare | 0.65% | 1.25% |
#27
6
Prev: #21
|
2.8 |
—
|
250,000 | 49.3% |
P
S
|
756,722 | $4,298,181 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 0.59% | 1.50% |
#28
13
Prev: #15
|
0.2 |
—
|
-405,000 | -30.0% |
P
S
|
942,932 | $3,922,597 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
STWD
STARWOOD PPTY T...
|
Real Estate | 0.48% | 0.73% |
#29
2
Prev: #27
|
2.7 |
—
|
37,810 | 23.8% |
P
S
|
196,355 | $3,216,295 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.36% | 0.62% |
#30
1
Prev: #29
|
3.1 |
—
|
80,000 | 80.0% |
P
S
|
180,000 | $2,392,200 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 0.34% | 1.18% |
#31
9
Prev: #22
|
0.1 |
—
|
-853,403 | -60.1% |
P
S
|
566,509 | $2,232,045 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 0.33% | — |
#32
Prev: #—
|
3.6 |
—
|
714,710 | — |
NEW
|
714,710 | $2,222,748 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CHYM
CHIME FINL INC
|
Technology | 0.28% | — |
#33
Prev: #—
|
3.6 |
—
|
89,878 | — |
NEW
|
89,878 | $1,840,701 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.24% | 3.58% |
#34
25
Prev: #9
|
0.1 |
—
|
-2,155,000 | -42.3% |
P
S
|
2,934,015 | $1,625,151 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
WW
WW INTL INC
|
Healthcare | 0.20% | 0.35% |
#35
1
Prev: #34
|
0.6 |
—
|
-11,235 | -11.7% |
P
S
|
84,399 | $1,348,696 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
MRKR
MARKER THERAPEU...
|
Healthcare | 0.12% | 0.19% |
#36
3
Prev: #39
|
1.0 |
—
|
no change | no change |
P
S
|
554,250 | $814,748 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
ERASCA INC
|
|
CALL Option | 0.12% | — |
#37
Prev: #—
|
3.5 |
—
|
100,000 | — |
NEW
|
100,000 | $795,000 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.12% | 0.70% |
#38
10
Prev: #28
|
1.0 |
—
|
no change | no change |
P
S
|
733,568 | $784,918 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.06% | — |
#39
Prev: #—
|
3.5 |
—
|
59,911 | — |
NEW
|
59,911 | $396,012 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
FLD
FOLD HLDGS INC
|
Financial Services | 0.06% | 0.30% |
#40
3
Prev: #37
|
1.0 |
—
|
no change | no change |
P
S
|
856,632 | $385,484 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
NIOBW
NIOCORP DEVS LT...
|
Unknown | 0.06% | 0.14% |
#41
Prev: #41
|
0.5 |
—
|
-51,820 | -16.2% |
P
S
|
268,280 | $380,958 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
ELEDON PHARMACE...
|
|
CALL Option | 0.04% | — |
#42
Prev: #—
|
3.5 |
—
|
200,000 | — |
NEW
|
200,000 | $285,000 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
RZLVW
REZOLVE AI PLC
|
Unknown | 0.03% | 0.05% |
#43
2
Prev: #45
|
1.0 |
—
|
no change | no change |
P
S
|
235,121 | $213,960 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
BNAIW
BRAND ENGAGEMEN...
|
Unknown | 0.03% | 0.11% |
#44
1
Prev: #43
|
0.5 |
—
|
-213,000 | -12.8% |
P
S
|
1,453,808 | $203,533 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
PIPR
PIPER SANDLER C...
|
Financial Services | 0.03% | 0.05% |
#45
1
Prev: #46
|
1.0 |
—
|
no change | no change |
P
S
|
2,428 | $175,642 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
ENGENE THERAPEU...
|
|
Unknown | 0.02% | — |
#46
Prev: #—
|
3.5 |
—
|
511,177 | — |
NEW
|
511,177 | $148,190 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
N/A
CALL
LARIMAR THERAPE...
|
|
CALL Option | 0.02% | — |
#47
Prev: #—
|
3.5 |
—
|
728,600 | — |
NEW
|
728,600 | $145,720 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
CELC
CELCUITY INC
|
Healthcare | 0.02% | — |
#48
Prev: #—
|
3.5 |
—
|
1,249 | — |
NEW
|
1,249 | $130,670 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
COMPASS THERAPE...
|
|
CALL Option | 0.02% | — |
#49
Prev: #—
|
3.5 |
—
|
303,800 | — |
NEW
|
303,800 | $106,330 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
N/A
STABLECOINX INC
|
|
Unknown | 0.02% | — |
#50
Prev: #—
|
3.5 |
—
|
250,000 | — |
NEW
|
250,000 | $102,500 | — | 13F Filing | 2026-06-30 | 2026-08-11 |
Showing 1-50 of 96 holdings